Jesper Hansen Bonde, PhD, Dipl.Med.Sci. Senior Researcher, Manager
机构: Molecular Pathology, Dept . Pathology, Copenhagen University Hospital, AHH-Hvidovre Hospital
主页: linkedin.com
每年引用次数
引用次数
引用: 3,675
H-指数: 35
I10-指数 : 80
出版物: 198
Association of defective monocyte chemotaxis with recurrent acute exacerbations in chronic obstructive lung disease.
Bonde J , Nielsen H
European journal of respiratory diseases 68 ( 3) 200 -206
16
1986
The effect of RU 41.740, an immune modulating compound, in the prevention of acute exacerbations in patients with chronic bronchitis.
Soes-Petersen U , Dahl R , Punakivi L , Edelstein R
European journal of respiratory diseases 69 ( 4) 235 -241
18
1986
Clinical Utility of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Systematic Review.
Jesper H. Bonde , Maria-Teresa Sandri , Devin S. Gary , Jeffrey C. Andrews
Journal of Lower Genital Tract Disease 24 ( 1) 1 -13
13
2020
Classification of high‐grade cervical intraepithelial neoplasia by p16ink4a, Ki‐67, HPV E4 and FAM19A4/miR124‐2 methylation status demonstrates considerable heterogeneity with potential consequences for management
Frederique J Vink , Stèfanie Dick , Daniëlle AM Heideman , Lise MA De Strooper
International journal of cancer 149 ( 3) 707 -716
34
2021
FAM19A4/miR124-2 methylation testing and human papillomavirus (HPV) 16/18 genotyping in HPV-positive women under the age of 30 years
Frederique J Vink , Chris JLM Meijer , Albertus T Hesselink , Arno N Floore
Clinical Infectious Diseases 76 ( 3) e827 -e834
6
2023
Caterino, TD, 29 Christensen, IJ, 14, 16 Christensen, RK, 6 Clemmesen, O., 7
T Agander , J Albrectsen , W Alpizar-Alpizar , RH Andersen
APMIS 121 ( 135) 31ă32 -31ă32
EFFECT OF BIOSTIM (RU-41-740) IN THE PREVENTION OF ACUTE EXACERBATION IN PATIENTS WITH CHRONIC-BRONCHITIS (CB)
J BONDE , R DAHL , R EDELSTEIN , A KOKJENSEN
EUROPEAN JOURNAL OF RESPIRATORY DISEASES 69 A21 -A21
1986
Improved flow cytometric identification of myelopoiesis by the simultaneous labelling with CD13, CD14 and CD66 monoclonal antibodies.
P Hokland , M Hokland , J Bonde , K Meyer
British Journal of Haematology 92 ( 2) 269 -279
12
1996
Chemotaxis and IL-8 receptor expression in B cells from normal and HIV-infected subjects.
M Storgaard , N Mukaida , K Thestrup-Pedersen , J Bonde
Journal of Immunology 158 ( 1) 475 -484
40
1997
P18-02. Peptide pulsed dendritic cells allows for induction of polyfunctional CD4+ T cell responses and help CD8+ T cell targeting subdominant CTL epitopes
A Fomsgaard , I Karlsson , H Kløverpris , J Bonde
Retrovirology 6 ( 3) 311
2009
High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders.
J U H Lam , K M Elfström , D M Ejegod , H Pedersen
British Journal of Cancer 118 ( 1) 138 -144
10
2018
EP248 VALHUDES: a protocol for VALidation of HUman papillomavirus assays and collection DEvices for HPV testing on Self-samples and urine samples
M Arbyn , E Peeters , G Donders , P De Sutter
International Journal of Gynecologic Cancer 29
1
2019
VALHUDES: a protocol for VALidation of HUman papillomavirus assays and collection DEvices for HPV testing on Self-samples and urine samples
M Arbyn , E Peeters , G Donders , P De Sutter
International Journal Of Gynecological Cancer 29 A196 -A196
2019
Clinical validation of the BD Onclarity HPV assay using a non-inferiority test
DM Ejegod , I Serrano , KS Cuschieri , WA Nussbaumer
J Med Microbiol Diagn S 3 2161 -0703
32
2013
Clinical Validation of the BD Onclarity™ HPV Assay Using a Non-Inferiority Test
DM Ejegod , I Serrano , KS Cuschieri , WA Nussbaumer
Journal of Medical Microbiology and Diagnosis 2015 0 -0
16
2015
HPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 Human Papillomavirus genotype microarray system
S Preisler , M Rebolj , D Ejegod , E Lynge
APMIS 122 30 -31
2014
Detection of high-grade CIN by four HPV assays in women with abnormal cytology
J Bonde , M Rebolj , S Preisler , D Ejegod
APMIS 122 6 -7
2014
Comparison of four HPV assays in a primary screening population on women>= 30 years of age
M Rebolj , D Ejegod , S Preisler , C Rygaard
APMIS 122 6 -6
2014
Experiences with molecular HPV testing using APTIMA, CLART, and cobas HPV test in SurePath liquid based cytology samples
DM Ejegod , M Rebolj , S Preisler , E Lynge
APMIS 121 18 -19
2013
APTIMA HPV assay testing on the PANTHER platform using SurePath samples
M Rebolj , S Preisler , DM Ejegod , J Bonde
APMIS 121 19 -19
2013